pembrolizumab (keytruda)

What are the Indications for Pembrolizumab in Gynecology?

Pembrolizumab is approved for use in several specific gynecological indications:
Advanced or metastatic cervical cancer with disease progression on or after chemotherapy.
Advanced endometrial cancer with a high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR) that has progressed following prior treatment and for which there are no satisfactory alternative treatment options.
Recurrent ovarian cancer in combination with chemotherapy or as monotherapy in certain genetic contexts.

Frequently asked queries:

What is Pembrolizumab (Keytruda)?
How is Pembrolizumab Used in Gynecological Cancers?
What are the Indications for Pembrolizumab in Gynecology?
How is Pembrolizumab Administered?
What are the Benefits of Pembrolizumab?
What Research is Ongoing?
How can we ensure early detection of gynecological conditions?
How is the HPV Vaccine Administered?
What Follow-up Care is Required?
What Role Does Delivery Play in Fetal Oxygenation?
Why Should You Pump Breast Milk?
How Do Gynecologists Manage Work-Life Balance?
What are the Treatment Options for Gynecological Issues?
How is a Culture Test Performed?
What is Real-Time PCR?
What is Cushing's Syndrome?
What are the Treatment Options for Thyroid Dysfunction in Gynecology?
How is PCR Performed?
What Precautions Should Be Taken During Gynecological Procedures?
What Should Patients Do if They Suspect Implant Migration?
Follow Us
Top Searches
Cystic Ovarian Disease Ectopic Pregnancy Endometriosis Menorrhagia Ultrasound

Partnered Content Networks

Relevant Topics